statutory communications 2025-2026 | Pfizer Limited

Contact Us

Investors

Careers

Science

Contact Us

Investor Relations

STATUTORY COMMUNICATIONS 2025 - 2026

E-voting results for the 74th Annual General Meeting held on July 21, 2025

Proceedings of the 74th Annual General Meeting

Change in Senior Management Personnel - 02.07.2025

Letter to shareholders providing the weblink for accessing the Annual Report.

Notice for closure of Trading Window - June 30, 2025

Intimation of appointment of Cost and Secretarial Auditor

Intimation of Record Date

Intimation of Date of Annual General Meeting

Outcome of the Board Meeting held on May 19, 2025

Notice for the Board Meeting – May 19, 2025

Intimation regarding change in Senior Management Personnel of the Company - 01.04.2025

Company Details

Board of Directors

Capital History

Financial Information

Financial Information

Policies & Procedures

Model Code of Conduct

Code for Independent Directors

Terms and Conditions of Appointment of Independent Directors

Whistle Blower/Vigil Mechanismwhistle-blower-vigil-mechanism

Policy on Related Party Transactions

Policy on Corporate Social Responsibility

Code for Fair Disclosure

Familiarization Program for Independent - Directors

Policy on criteria for determining materiality of - events

Archival policy for website content

Dividend Distribution Policy

The Blue Book – Summary of Pfizer Polices on - Business Conduct

Analysts Teleconference

Analysts Teleconference

Investor Services

Frequently Asked Questions

Listing & Other Information

Unclaimed Dividend & Shares

Grievance Redressal

Statutory Communications

Compliances under Listing Regulations 2015

Corporate Governance Report

Shareholding Pattern

Newspaper Advertisements

About Us Our People Our Community Efforts Our Products

Investors Career Media Adverse Event Reporting Health Care Professionals

Terms of Use Privacy Policy Contact Us

Copyright © 2002- 2021 Pfizer Inc. All rights reserved.